Moreover, although functional outcome differences (NIHSS, modified Rankin Scale, Barthel Index) in the global cohort did not reach statistical significance, a post hoc subgroup analysis excluding patients undergoing endovascular therapy showed that 36% of DM199 recipients achieved an NIHSS score of 0–1, compared with 14% in the placebo group.
← all excerpts
Endothelial triple-pathway vasorelaxation as an adjunctive strategy in resistant hypertension.
1
—
—